TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive In Brief: Newell Tells Advisory Committee It Isn’t a Lobbying Group, “Accept What We Give You” April 8, 1977